You are here: Industry Insights > teva

News List

Teva CEO Erez Vigodman steps down from role firstwordpharma
February 08, 2017
Teva announced that CEO Erez Vigodman is stepping down from his position following an agreement with the board of directors. "I believe that now is the right time for me to step down," said Vigodman, adding "I am confident that the company's future is bri
Teva Appoints Interim Chief Executive Officer americanpharmaceuticalreview
February 08, 2017
Teva Pharmaceutical Industries has announced that Dr. Yitzhak Peterburg, who has served as Chairman of the Teva Board of Directors since January 2015, has been appointed Interim President and Chief Executive Officer, effective immediately.
Teva Confirms Generic Victoza® Patent Challenge in the United States americanpharmaceuticalreview
February 06, 2017
Teva Pharmaceutical Industries has filed an abbreviated new drug application (ANDA) with the U.S.
FDA Approves ArmonAir RespiClick drugs.com
January 30, 2017
Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma
FDA Approves AirDuo RespiClick drugs.com
January 30, 2017
Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma
FDA Approves Vantrela ER drugs.com
January 19, 2017
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the U.S. Food and Drug Administration (FDA) approved Vantrela ER (hydrocodone bitartrate) extended-release tablets [CII] formulated with Teva’s proprietary abuse deterrence technolo

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page